Otsuka Pharmaceutical Europe Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Private

  • Employees
  • 500

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $81.3K

  • Investors
  • 1

Otsuka Pharmaceutical Europe General Information

Description

Manufacturer of healthcare products intended for the treatment of diseases and nutraceutical products. The company distributes pharmaceutical products and research, develops and markets products for cardiovascular, gastrointestinal and central nervous system disorders, thereby developing innovative products and medical devices that address high unmet medical needs.

Contact Information

Formerly Known As
Intercede 1283 Limited
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Corporate Office
  • 2 Windsor Dials
  • Arthur Road
  • Windsor SL4 1RS
  • England, United Kingdom
+44 020
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 2 Windsor Dials
  • Arthur Road
  • Windsor SL4 1RS
  • England, United Kingdom
+44 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Otsuka Pharmaceutical Europe Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Grant 01-Jun-2020 $81.3K Completed Generating Revenue
To view Otsuka Pharmaceutical Europe’s complete valuation and funding history, request access »

Otsuka Pharmaceutical Europe Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Otsuka Pharmaceutical Europe Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovate UK Government
To view Otsuka Pharmaceutical Europe’s complete investors history, request access »

Otsuka Pharmaceutical Europe Investments (1)

Otsuka Pharmaceutical Europe’s most recent deal was a Later Stage VC with Holmusk for . The deal was made on 06-Jan-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Holmusk 06-Jan-2023 Later Stage VC Enterprise Systems (Healthcare)
To view Otsuka Pharmaceutical Europe’s complete investments history, request access »

Otsuka Pharmaceutical Europe Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
Otsuka Pharmaceutical Netherlands Amsterdam, Netherlands 2018
Otsuka Pharmaceutical France Rueil-Malmaison, France 2004
Otsuka Pharma Scandinavia Stockholm, Sweden 2001
Otsuka Pharma Frankfurt, Germany 1998

Otsuka Pharmaceutical Europe FAQs

  • When was Otsuka Pharmaceutical Europe founded?

    Otsuka Pharmaceutical Europe was founded in 1997.

  • Where is Otsuka Pharmaceutical Europe headquartered?

    Otsuka Pharmaceutical Europe is headquartered in Windsor, United Kingdom.

  • What is the size of Otsuka Pharmaceutical Europe?

    Otsuka Pharmaceutical Europe has 500 total employees.

  • What industry is Otsuka Pharmaceutical Europe in?

    Otsuka Pharmaceutical Europe’s primary industry is Drug Discovery.

  • Is Otsuka Pharmaceutical Europe a private or public company?

    Otsuka Pharmaceutical Europe is a Private company.

  • What is Otsuka Pharmaceutical Europe’s current revenue?

    The current revenue for Otsuka Pharmaceutical Europe is .

  • Who are Otsuka Pharmaceutical Europe’s investors?

    Innovate UK has invested in Otsuka Pharmaceutical Europe.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process